BUSINESS
Moderna’s Cancer Vaccine Trial Data Raises Concerns Among Investors
Moderna's melanoma vaccine shows promise but fails to meet high investor expectations, affecting stock prices.
Moderna's melanoma vaccine shows promise but fails to meet high investor expectations, affecting stock prices.
Biocon has moved up in the Top 10 Global Biotech Employers ranking for 2018 and continues to be the only company from…